Venture Debt Explained: What It Costs Founders and When It Makes Sense
- Giorgi Meskhi
- Aug 14
- 10 min read
US venture debt volume hit a new record in 2025, surpassing 2024’s $61.1 billion high, according to PitchBook. Deal count fell 19% at the same time. Fewer deals, much larger checks. AI infrastructure companies are pulling billion-dollar facilities. The average deal size has more than doubled since 2020.
That headline number does not tell the story most founders need to hear. Venture debt is not just a late-stage instrument for AI unicorns. It is available to post-seed and Series A companies with the right VC backing, and it is one of the most misused tools in startup financing. Founders take it when they shouldn’t, or avoid it when it would genuinely serve them, because they don’t understand what it actually costs.
We have reviewed the capital structure on more than 600 fundraising engagements at RunwayTeam. This guide covers what venture debt is, how the structure and pricing work, the specific situations where it makes sense, and the three scenarios where it will hurt you.
What Is Venture Debt?
Venture debt is a form of debt financing designed for venture-backed startups. It is extended by banks and specialist lenders - not equity investors - and repaid with interest over a fixed term, typically 24 to 36 months. Unlike a conventional bank loan, it is underwritten primarily on the strength of the company’s VC backing and growth trajectory, not its current cash flow or hard assets. A pre-profitable startup with strong institutional investors can qualify for venture debt where it would not qualify for any traditional lending product.
Venture debt is often described as non-dilutive financing. That description is technically accurate and practically incomplete. Venture debt facilities almost always include warrant coverage - a small equity kicker that gives the lender the right to purchase shares at the current round price. The dilution from warrants is real, just smaller and deferred compared to issuing a new equity round. Understanding that distinction is the foundation of any honest venture debt evaluation.
Venture debt is not a substitute for equity. Every experienced lender underwrites based on the assumption that equity investors will continue to support the company. Venture debt follows venture capital - it does not replace it. If your VC backers are pulling back, a lender will sense that before you announce it. Venture debt works best immediately after a priced equity round, when lender risk is at its lowest and warrant terms are most favorable. It is not a bridge away from a struggling raise - it is a complement to a successful one.
How Venture Debt Works
The loan structure
Most venture debt facilities are sized at 25-33% of the last equity round. A startup that raised a $9M Series A would typically qualify for a $2M-3M facility. The loan is repaid over 24-36 months, usually with a 6-12-month interest-only period followed by principal amortization. Interest rates currently range from 8-15% per annum, reflecting the post-SVB rate environment where SOFR sits around 4.5% and lender spreads run an additional 6-9%, per re:cap’s 2026 venture debt analysis. Higher-risk profiles or early-stage companies pay at the top of that range; well-established post-Series A companies with strong revenue track records often negotiate toward the lower end.
The warrant mechanic (the detail most founders miss)
Alongside the loan, lenders typically receive warrant coverage - the right to purchase a specified dollar amount of equity in the company at the per-share price from the most recent equity round. Coverage is typically 5-20% of the loan amount. Here is what that looks like in practice.
A $2M venture debt facility at 10% warrant coverage gives the lender the right to purchase $200K worth of shares at the current round price. If your last round priced at $1 per share (on a $10M post-money valuation with 10 million total shares), the lender receives warrants to purchase 200,000 shares. At that point, the warrants represent approximately 2% dilution on a fully diluted basis - real but modest.
The lender may or may not exercise those warrants. If they do, it happens at the original strike price regardless of how the company has grown. If your share price has tripled by then, the lender pays $1 for something worth $3. That upside is the lender’s compensation for the risk of lending to a pre-profitable company. For the founder, the dilution at exercise is fixed and calculable in advance - which is the point.
The draw schedule
Most venture debt facilities are not drawn in a single tranche. Lenders typically structure the facility with an initial draw at closing and one or two subsequent tranches available over the following 6-12 months, contingent on meeting specific milestones (e.g., a revenue target, a product launch, or a subsequent equity round). This matters for runway planning: the full facility amount is not available on day one, and you need to model the specific draw dates into your cash projection rather than treating the total facility as immediately usable capital.
Venture Debt vs. Equity: The Decision Framework
Venture debt and equity are not competing answers to the same question. They are different tools with different costs, different obligations, and different appropriate use cases. Here is how to evaluate them side by side.
The most common mistake in this comparison is treating dilution as the only variable. Venture debt has lower dilution costs, which look attractive on a spreadsheet. But it introduces repayment risk - a fixed obligation that equity never creates. A company that takes on $3M in venture debt and then misses its revenue targets for three consecutive quarters faces a debt-service problem on top of an operational one. That combination is harder to navigate than a dilutive equity round would have been. The right question is not “which is cheaper?” but “which matches the risk profile of what we are using the capital for?”
When Venture Debt Makes Sense
Bridging to a defined milestone before the next equity round
This is the cleanest use case. You have closed a Series A, you are 18 months from the milestone that will anchor your Series B valuation, and you need an additional $2M to get there without opening a new equity conversation. A venture debt facility extends the runway, you hit the milestone, the Series B prices at a meaningfully higher valuation, and the dilution from warrants is a fraction of what a bridge equity round would have cost. The valuation you avoid negotiating is as important as the dilution you avoid issuing.
Extending runway immediately after a priced round
Taking venture debt alongside or within a few months of closing an equity round is when lender terms are most favorable. The VC backing is fresh, the risk to the lender is lowest, and warrant coverage is typically at the lower end of the range. Some founders wait too long - approaching lenders six months into a runway problem - and find terms are worse, or the facility is unavailable entirely. If you are going to take venture debt, the right time is early in the runway clock, not late.
Funding capital expenditures that equity investors won't back
Hardware, lab equipment, infrastructure build-outs, and other capital expenditures often sit awkwardly in a VC-funded company. Equity investors underwrite based on software-like return profiles and prefer capital to fund people and growth rather than equipment. Venture debt can fund the capex specifically, with the equipment sometimes serving as partial collateral. This is a narrow but genuine use case, particularly common in hardware, medtech, and climate tech. In these situations, the use-of-funds story for the debt facility needs to be as tight as that for any equity round.
When to Avoid Venture Debt
When equity backing is not firmly in place
Most venture debt lenders require evidence of recent, committed VC backing as a condition of the facility. This is not a formality - it is the underwriting foundation. Founders who approach lenders while between investors, or whose existing VCs are visibly pulling back, will find the terms punishing or the facility unavailable. Venture debt is not a last resort; it is a complement to a funded position.
When the capital is funding operating losses, not a milestone
A $3M venture debt facility spread over 30 months of operating losses is not a bridge. It is a slow drain with a fixed repayment schedule at the end. The discipline venture debt imposes is that the money needs a clear job: a revenue milestone, a product launch, a specific hire class. If the use of funds is ‘general operations’ or ‘extending runway while we figure out growth,’ the fixed repayment schedule will arrive before the growth does. This is where modeling the debt service against realistic revenue scenarios becomes essential before signing.
When the all-in cost exceeds the dilution cost of equity
At certain valuation levels and certain interest rate environments, the total cost of venture debt - interest payments plus warrant dilution - can exceed the dilution cost of raising equity. This comparison is not static; it depends on your current valuation, the size of the facility, the negotiated warrant coverage, and the prevailing interest rate environment. It requires a model. If you have not run the numbers side by side before signing, you are making the decision without the information needed to determine whether it is actually the right one. The financial model that enables this comparison is the same one investors will scrutinize in your next round.
How Venture Debt Appears on the Cap Table
Before the facility is drawn, venture debt does not appear on the cap table. Once drawn, the loan sits on the balance sheet as a debt obligation. The warrants attached to the facility appear in the fully diluted cap table notes as potential dilution - the same way a SAFE or convertible note sits as a potential obligation before conversion. No new shares exist yet.
If the lender exercises the warrants, new shares are issued at the strike price set at the time of the facility. Using the example from Section 2: the lender exercises 200,000 warrants at $1 per share, paying $200K to the company. The company issues 200,000 new shares. The founder’s ownership percentage drops by approximately 2% on a fully diluted basis. That is the full dilution event from the warrants.
Two important notes. First, lenders often do not exercise their warrants immediately, or at all, if the terms are not advantageous. They expire after a set period. Second, if the company grows significantly before exercise, the warrant becomes very valuable to the lender even though the founder’s cost (the 2% dilution) was priced at the original round valuation. This asymmetry is one reason warrant coverage should be negotiated actively - even a reduction from 10% to 7% coverage on a $3M facility saves $90K of warrant value for the founder.
Common Venture Debt Mistakes
Taking more than needed. The debt service on a $5M facility is materially harder to manage than on a $ 2.5 M facility. Size the facility to the specific use case, not to the maximum available. Every dollar of principal you do not draw is a dollar of interest you do not pay.
Ignoring the material adverse change clause. Most venture debt agreements include a MAC clause that allows the lender to accelerate repayment if the company materially deteriorates - such as a significant revenue decline, the loss of a key customer, or a failed equity raise. Founders who do not read this clause carefully often discover it at the worst possible moment.
Not negotiating warrant coverage. Warrant coverage is more negotiable than most founders assume. Lenders competing for a deal, or lending immediately after a strong equity round, will often accept lower coverage. The difference between 15% and 8% coverage on a $3M facility is $210K of warrant value. That negotiation takes an hour.
Using venture debt as a substitute for an equity round. Venture debt requires repayment. A failed equity raise 18 months later does not eliminate the repayment obligation. Founders who take venture debt in lieu of a struggling equity process often compound the problem rather than solving it.
Signing without a financial model. The monthly debt service, modeled against your actual revenue scenarios, is the number that determines whether the facility serves or traps you. Optimistic revenue assumptions and a venture debt payment schedule are a dangerous combination. Stress-test the repayment against a scenario in which revenue grows 30% more slowly than planned.
FAQs
What is venture debt?
Venture debt is a form of debt financing for venture-backed startups, offered by banks and specialist lenders alongside or shortly after an equity round. It is repaid with interest over a fixed term, typically 24-36 months, and usually includes warrant coverage - the right for the lender to purchase a small amount of equity at the current round price. It is underwritten on the strength of the startup’s VC backing, not its current cash flow.
How is venture debt different from a bank loan?
A conventional bank loan requires revenue, assets, or positive cash flow as collateral. Venture debt requires VC backing. A pre-profitable startup with strong institutional investors can qualify for venture debt that no conventional lender would touch. The tradeoff is a higher interest rate and warrant coverage that conventional loans do not carry.
Is venture debt dilutive?
Technically non-dilutive - no new shares are issued when you draw the facility. Practically semi-dilutive - warrant coverage (typically 5-20% of the loan amount) gives the lender the right to purchase equity at the current round price. On a $2M facility at 10% warrant coverage, the lender holds warrants worth $200K of equity at the current price, representing approximately 2% dilution if exercised. That is real, but far less than a new equity round at the same capital amount.
When does venture debt make sense for a startup?
Venture debt makes most sense immediately after closing an equity round (when lender terms are best), when the capital has a specific job (a defined milestone, a capex investment, a revenue bridge), and when the total cost - interest plus warrants - is lower than the dilution cost of raising equity at the current valuation. It does not make sense as a substitute for a failing equity raise, or when the use of funds is general operations without a clear milestone at the end.
What is warrant coverage in venture debt?
Warrant coverage is the equity component of a venture debt deal. It gives the lender the right to purchase a specified dollar amount of equity in the company at the per-share price from the most recent equity round. Coverage is typically 5-20% of the loan amount. On a $3M facility at 10% coverage, the lender holds warrants to purchase $300K of equity at the current round price. The warrants are exercised at the lender’s discretion within a set window - if the company grows and the share price rises, the warrants become valuable. If the company stagnates, the lender may not exercise at all.
How much venture debt can a startup raise?
Most facilities are sized at 25-33% of the last equity round. A $9M Series A would typically support a $2M-3M venture debt facility. The exact amount depends on the lender, the quality of the VC backers, the company’s sector, and its revenue trajectory. Some lenders extend larger facilities to capital-efficient companies with strong recurring revenue, particularly at later stages. Deal sizes have grown sharply in recent years - the average venture debt deal size has more than doubled since 2020, driven largely by late-stage and AI-focused companies.
Venture Debt Changes Both Your Debt Service Math And Your Cap Table
RunwayTeam builds the financial model that stress-tests the repayment schedule against your actual revenue scenarios - before you sign the facility agreement.
